Mutations in ANTXR1 cause GAPO syndrome.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 23602711.
- Also identified by DOI 10.1016/j.ajhg.2013.03.023 and PMC identifier 3644626.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The genetic cause of GAPO syndrome, a condition characterized by growth retardation, alopecia, pseudoanodontia, and progressive visual impairment, has not previously been identified. We studied four ethnically unrelated affected individuals and identified homozygous nonsense mutations (c.262C>T [p.Arg88*] and c.505C>T [p.Arg169*]) or splicing mutations (c.1435-12A>G [p.Gly479Phefs*119]) in ANTXR1, which encodes anthrax toxin receptor 1. The nonsense mutations predictably trigger nonsense-mediated mRNA decay, resulting in the loss of ANTXR1. The transcript with the splicing mutation theoretically encodes a truncated ANTXR1 containing a neopeptide composed of 118 unique amino acids in its C terminus. GAPO syndrome's major phenotypic features, which include dental abnormalities and the accumulation of extracellular matrix, recapitulate those found in Antxr1-mutant mice and point toward an underlying defect in extracellular-matrix regulation. Thus, we propose that mutations affecting ANTXR1 function are responsible for this disease's characteristic generalized defect in extracellular-matrix homeostasis.
Medical subject headings
- Alopecia
- Anodontia
- Chromosomes, Human, Pair 2
- Extracellular Matrix
- Genetic Predisposition to Disease
- Growth Disorders
- Homeostasis
- Neoplasm Proteins
- Optic Atrophies, Hereditary
- Receptors, Cell Surface